Join us for an overview of our full range of mAb production solutions to address todays and future needs of mAb producers.
Platform processes for mAb manufacturing has become the norm for the majority of the bioprocess industry. MAb producers are today faced with increasing pressure from both internal and external sources (e.g. biosimilars, patent expirations, facility fit constraints, etc.), making investigations of process intensification approaches a necessity. This webinar will focus on our full range of mAb production solutions we have developed and are continuing to develop to address the needs of mAb producers today and in the future.
In this webinar you will learn: